- Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

Study shows Nilvadipine slows early-stage Alzheimer’s disease

The study found that Nilvadipine-treated patients with very mild Alzheimer’s disease show less cognitive decline over an 18-month period than placebo-treated patients. Credit: National Institute on Aging, NIH.